Haematology and Oncology
The Division of Haematology/Oncology was set up by Prof. Patrick Yuen in 1980s after the opening of Prince of Wales Hospital. The first paediatric bone marrow transplantation in Hong Kong was performed in February 1991. The Lady Pao Children’s Cancer Centre was formally opened in 1995. In 2019, with integration of paediatric oncology service in Hong Kong, the paediatric Haematology/Oncology team of CUHK was translocated to Hong Kong Children’s Hospital (HKCH). In collaboration with paediatric teams from other hospitals in Hong Kong, the team continues to provide specialised clinical services to paediatric patients with cancers including haematological malignancies, solid tumors, and brain tumours and with haematological diseases in HKCH. The Haematology/Oncology unit in HKCH is equipped with 24 in-patient beds for patients with leukaemia / lymphoma and severe haematological diseases, 26 in-patient beds for patients with solid tumour and neuro-oncology tumors, and 12 in-patient beds for haematopoietic stem cell transplantation. The unit receives referrals of patients age less than or equal to 18 with haematological or oncological problems across the territory. At the same time, the team continues to provide service to children with haematological diseases and long-term survivors of childhood cancer in Li Ka Shing Specialist Outpatient Clinic in Prince of Wales Hospital.
The team, as part of the Haematology/Oncology team in HKCH, provides paediatric oncology training for medical, nursing and technology staffs. The paediatric Haematology/Oncology team, CUHK is collaborating with the Seventh Affiliated Hospital, Sun Yat-sen Hospital, and providing specialty training on clinical management, teaching, and clinical and basic science research on paediatric haematology and oncology.
The sub-specialty of Paediatric Haematology and Oncology is undergoing accreditation.
The team is active in clinical, laboratory and translational research in malignant and non-malignant conditions:
Coordinating centre for Hong Kong paediatric oncology units in international (IBFM Study Group) and national clinical trials on Acute Lymphoblastic Leukaemia
Minimal Residual Disease study in leukaemia
Chimeric Antigen Receptor T (CAR-T) Cell therapy
Drug sensitivity profiling and translational research in childhood acute leukaemia
Sponsored clinical trial on anti-TFPI agents in patients with haemophilia.
Bone mineral density in thalassaemia major patients
Stem cell research with special interest on cord blood biology
Long term follow up of childhood cancer survivors in collaboration with School of Pharmacy